These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31089876)

  • 1. Patients with alopecia areata show signs of insulin resistance.
    Shahidi-Dadras M; Bahraini N; Rajabi F; Younespour S
    Arch Dermatol Res; 2019 Sep; 311(7):529-533. PubMed ID: 31089876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is increased in alopecia areata patients.
    Karadag AS; Ertugrul DT; Bilgili SG; Takci Z; Tutal E; Yilmaz H
    Cutan Ocul Toxicol; 2013 Jun; 32(2):102-6. PubMed ID: 22916967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin-2 and insulin as new biomarkers of alopecia areata.
    Waśkiel-Burnat A; Niemczyk A; Chmielińska P; Muszel M; Zaremba M; Rakowska A; Olszewska M; Rudnicka L
    PLoS One; 2022; 17(5):e0268086. PubMed ID: 35639706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss.
    Serarslan G; Özcan O; Okyay E; Ünlü B; Karadağ M
    Ir J Med Sci; 2021 Aug; 190(3):1015-1020. PubMed ID: 33083959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis.
    Rasheed Z; Alzolibani AA; Al-Shobaili HA; Saif GB; Al Robaee AA
    Immunol Lett; 2014 Jul; 160(1):50-57. PubMed ID: 24694751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Deficiency in Alopecia Areata.
    Ghafoor R; Anwar MI
    J Coll Physicians Surg Pak; 2017 Apr; 27(4):200-202. PubMed ID: 28492146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of β-hydroxybutyrate in inducing inflammation in alopecia areata.
    Shin JM; Son S; Jung KE; Kim CD; Lee Y
    Exp Dermatol; 2024 Jun; 33(6):e15117. PubMed ID: 38884504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
    Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
    J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgenetic alopecia and insulin resistance in young men.
    González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata: autoimmune basis of hair loss.
    Alexis AF; Dudda-Subramanya R; Sinha AA
    Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
    Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.
    Salem SA; Asaad MK; Elsayed SB; Sehsah HM
    Int J Dermatol; 2016 Dec; 55(12):1357-1361. PubMed ID: 27420731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases.
    Arousse A; Boussofara L; Mokni S; Gammoudi R; Saidi W; Aounallah A; Belajouza C; Ghariani N; Denguezli M; Nouira R
    Int J Dermatol; 2019 Jul; 58(7):811-815. PubMed ID: 30677128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid autoimmunity in patients with alopecia areata.
    Kasumagić-Halilović E
    Acta Dermatovenerol Croat; 2008; 16(3):123-5. PubMed ID: 18812059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma in alopecia areata.
    Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
    Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse alopecia areata is associated with intense inflammatory infiltration and CD8+ T cells in hair loss regions and an increase in serum IgE level.
    Zhao Y; Zhang B; Caulloo S; Chen X; Li Y; Zhang X
    Indian J Dermatol Venereol Leprol; 2012; 78(6):709-14. PubMed ID: 23075639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.
    Atwa MA; Youssef N; Bayoumy NM
    Int J Dermatol; 2016 Jun; 55(6):666-72. PubMed ID: 26235375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata and overt thyroid diseases: A nationwide population-based study.
    Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM
    J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia.
    Fawzi MM; Mahmoud SB; Ahmed SF; Shaker OG
    J Cosmet Dermatol; 2016 Dec; 15(4):318-323. PubMed ID: 27151518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.